Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2-Reference-Cited by-同舟云学术

Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2

Published:2003-08 Issue:4 Volume:4 Page:252-261
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Amin J¹,Moore A.¹,Carr A²,French M.A.³,Law M¹,Emery S¹,Cooper D.A¹²

Affiliation:

1. National Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, NSW, Australia

2. HIV Immunology and Infectious Disease Clinical Services Unit, St Vincent's Hospital, Sydney, Australia

3. Department of Clinical Immunology and Communicable Diseases ServicesRoyal Perth Hospital, Perth, Australia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

https://www.tandfonline.com/doi/pdf/10.1310/K2U9-QC2V-1Y3V-5DYF

Reference12 articles.

1. Antiretroviral Treatment for Adult HIV Infection in 2002

2. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

3. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

4. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uptake of WHO Recommendations for First-Line Antiretroviral Therapy in Kenya, Uganda, and Zambia;PLOS ONE;2015-03-25

2. Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals;Cochrane Database of Systematic Reviews;2010-08-04

3. HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies;National Institute of Allergy and Infectious Diseases, NIH;2009

4. Toxicities Associated with Dual Nucleoside Reverse‐Transcriptase Inhibitor Regimens in HIV‐Infected Children;The Journal of Infectious Diseases;2008-12

5. Long-Term Subcutaneous Tissue Changes Among Antiretroviral-Naive Persons Initiating Stavudine, Zidovudine, or Abacavir With Lamivudine;JAIDS Journal of Acquired Immune Deficiency Syndromes;2008-05-01